ALIVAMAB Trademark

Trademark Overview

On Friday, December 21, 2018, a trademark application was filed for ALIVAMAB with the United States Patent and Trademark Office. The USPTO has given the ALIVAMAB trademark a serial number of 88238389. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, November 8, 2021. This trademark is owned by Ablexis, LLC. The ALIVAMAB trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Pharmaceuticals, namely, preparations for antibody and antibody-derivative development

Biological preparations for use in industry and science, namely, preparations for antibody development
alivamab

General Information

Serial Number88238389
Word MarkALIVAMAB
Filing DateFriday, December 21, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, November 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2019

Trademark Statements

Goods and ServicesPharmaceuticals, namely, preparations for antibody and antibody-derivative development
Goods and ServicesBiological preparations for use in industry and science, namely, preparations for antibody development

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, January 14, 2019
Primary Code001
First Use Anywhere DateMonday, August 7, 2017
First Use In Commerce DateMonday, August 7, 2017
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 14, 2019
Primary Code005
First Use Anywhere DateMonday, August 7, 2017
First Use In Commerce DateMonday, August 7, 2017

Trademark Owner History

Party NameAblexis, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121
Party NameAblexis, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, November 8, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, November 8, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 20, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 20, 2021FINAL REFUSAL E-MAILED
Tuesday, April 20, 2021SU - FINAL REFUSAL - WRITTEN
Tuesday, March 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 26, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 29, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2020NON-FINAL ACTION E-MAILED
Tuesday, September 29, 2020SU - NON-FINAL ACTION - WRITTEN
Saturday, September 19, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 17, 2020USE AMENDMENT FILED
Thursday, September 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 17, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 17, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, March 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 17, 2020SOU EXTENSION 1 GRANTED
Tuesday, March 17, 2020SOU EXTENSION 1 FILED
Tuesday, March 17, 2020TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 17, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 17, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 17, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 17, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 23, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 29, 2019DIVISIONAL PROCESSING COMPLETE
Friday, May 10, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, May 28, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 17, 2019ASSIGNED TO LIE
Friday, May 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 10, 2019TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, March 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2019NON-FINAL ACTION E-MAILED
Wednesday, March 20, 2019NON-FINAL ACTION WRITTEN
Monday, March 18, 2019ASSIGNED TO EXAMINER
Monday, January 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 25, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

alivamab antibody preparations development namely industry science derivative pharmaceuticals biological